Ascletis Pharma, Inc.HKEX: 1672

Next Day Disclosure Return

Oct 23, 2026 at 6:02 AM EDT · Issued by Ascletis Pharma, Inc. via HKEXnews

Filed with HKEX · Stock code 1672 · Oct 23, 2026 at 6:02 AM EDT

On 6ix: 6ix.com/news/next-day-disclosure-return-1531

View Attachment

6ix is reading this filing.

View original source (HKEXnews)Ascletis Pharma, Inc. on 6ix

Earlier from Ascletis Pharma

Voluntary announcement - ascletis' strategic partner sagimet announces first patient dosed in phase iii U.S. clinical trial of denifanstat (ASC40) for moderate to severe acneOct 23
Voluntary announcement - ascletis announces positive preclinical data for the most comprehensive once-weekly oral peptide pipeline for the treatment of obesityOct 20

All Ascletis Pharma news releases

Follow Ascletis Pharma into a list and get an email when it puts out news.

Follow Ascletis Pharma